Cargando…

Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin

AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vugt, Heidi A, Boels, Anne Meike, de Weerdt, Inge, de Koning, Eelco JP, Rutten, Guy EHM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314047/
https://www.ncbi.nlm.nih.gov/pubmed/30643392
http://dx.doi.org/10.2147/PPA.S188391
_version_ 1783384061869293568
author van Vugt, Heidi A
Boels, Anne Meike
de Weerdt, Inge
de Koning, Eelco JP
Rutten, Guy EHM
author_facet van Vugt, Heidi A
Boels, Anne Meike
de Weerdt, Inge
de Koning, Eelco JP
Rutten, Guy EHM
author_sort van Vugt, Heidi A
collection PubMed
description AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in patient activation. METHODS: In this cross-sectional study, baseline data from a Dutch nationwide study were analyzed. Patient activation was assessed with the Patient Activation Measure 13. A linear mixed model was used to take clustering into account. RESULTS: In total, 1,189 persons were included (310 of whom were on insulin), enrolled via 47 general practices and six hospitals. Their mean Patient Activation Measure 13 score was 59±12. We found no association between insulin therapy and patient activation. In the multivariable analysis, individuals with a better health status, very good or very poor social support (vs good social support), individuals who felt they had greater control over their illness and those with a better subjective understanding of their illness showed higher patient activation. Individuals with a lower educational level and those who expected their illness to continue showed a lower activation level. CONCLUSION: Patient activation does not differ between individuals with type 2 diabetes mellitus on insulin therapy and those on other therapies.
format Online
Article
Text
id pubmed-6314047
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63140472019-01-14 Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin van Vugt, Heidi A Boels, Anne Meike de Weerdt, Inge de Koning, Eelco JP Rutten, Guy EHM Patient Prefer Adherence Original Research AIM: This study explored the relationship between insulin use and patient activation (a person’s internal readiness and capabilities to undertake health-promoting actions) in individuals with type 2 diabetes mellitus and aimed to identify demographic, clinical and psychosocial factors involved in patient activation. METHODS: In this cross-sectional study, baseline data from a Dutch nationwide study were analyzed. Patient activation was assessed with the Patient Activation Measure 13. A linear mixed model was used to take clustering into account. RESULTS: In total, 1,189 persons were included (310 of whom were on insulin), enrolled via 47 general practices and six hospitals. Their mean Patient Activation Measure 13 score was 59±12. We found no association between insulin therapy and patient activation. In the multivariable analysis, individuals with a better health status, very good or very poor social support (vs good social support), individuals who felt they had greater control over their illness and those with a better subjective understanding of their illness showed higher patient activation. Individuals with a lower educational level and those who expected their illness to continue showed a lower activation level. CONCLUSION: Patient activation does not differ between individuals with type 2 diabetes mellitus on insulin therapy and those on other therapies. Dove Medical Press 2018-12-28 /pmc/articles/PMC6314047/ /pubmed/30643392 http://dx.doi.org/10.2147/PPA.S188391 Text en © 2019 van Vugt et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
van Vugt, Heidi A
Boels, Anne Meike
de Weerdt, Inge
de Koning, Eelco JP
Rutten, Guy EHM
Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title_full Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title_fullStr Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title_full_unstemmed Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title_short Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
title_sort patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314047/
https://www.ncbi.nlm.nih.gov/pubmed/30643392
http://dx.doi.org/10.2147/PPA.S188391
work_keys_str_mv AT vanvugtheidia patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin
AT boelsannemeike patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin
AT deweerdtinge patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin
AT dekoningeelcojp patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin
AT ruttenguyehm patientactivationinindividualswithtype2diabetesmellitusassociatedfactorsandtheroleofinsulin